Search Results

Below are the search engine results of your query.

Showing 1-10 of 18 results for "R142b"

Vertrel™ Specialty Fluids

Vertrel™ specialty fluids act as fluorinated solvents, cleaners, and more.

The Chemours Company Reports Fourth Quarter and Full Year 2018 Results

Full Year 2018 Highlights Net Sales of $6.6 billion, up 7% Net Income of $995 million, up 33%, with EPS of $5.45, up 39% Adjusted Net Income of $1.0 billion, up 42%, with Adjusted EPS of $5.67, up 48% Adjusted EBITDA of $1.7 billion, up 22% Returned over $790 million to shareholders through share repurchases and dividends Fourth Quarter 2018 Highlights Net Sales of $1.5 billion Net Income of $142 ...

The Chemours Company Reports First Quarter 2017 Results; Significant Earnings Improvements in All Segments

First Quarter 2017 Highlights Net Sales of $1.4 billion , up 11%, including impacts from divestitures Net Income of $150 million , up $99 million with EPS of $0.79 , up $0.51 per diluted share Adjusted EBITDA of $285 million , up 123%, demonstrating margin improvement across all segments Adjusted Net Income of $142 million , up $131 million with Adjusted EPS of $0.75 , up $0.69 per diluted share A...

Consent Order Compliance

Documents have been submitted by The Chemours Company.

Fayetteville Works

We are committed to taking a leadership role in environmental stewardship.

The Chemours Company Reports Strong Second Quarter Results and Increases Full-Year 2017 Outlook

Second Quarter 2017 Highlights Net Sales of $1.6 billion , up 15% Net Income of $161 million , up $179 million with EPS of $0.84 , up $0.94 per diluted share Adjusted EBITDA of $361 million , up $174 million , driven by strong year-over-year volume and price improvement in Titanium Technologies and Fluoroproducts Adjusted Net Income of $166 million , up $117 million with Adjusted EPS of $0.87 , up...

The Chemours Company Reports First Quarter 2019 Results

Continuing to Aggressively Return Capital to Shareholders First Quarter 2019 Highlights Net Sales of $1.4 billion Net Income of $94 million, with EPS of $0.55 Adjusted Net Income of $109 million, with Adjusted EPS of $0.63 Adjusted EBITDA of $262 million Returned $261 million to shareholders through share repurchases The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leadi...

Vertrel™ XSi Specialty Fluid

Vertrel™ XSi is specially designed for use in the medical industry.

The Chemours Company Reports Fourth Quarter and Full Year 2019 Results

Full Year 2019 Results In-line with Updated Guidance Full Year 2019 Results Net Sales of $5.5 billion Net Income of $(52) million with EPS of $(0.32) Adjusted Net Income of $419 million with Adjusted EPS of $2.51 Adjusted EBITDA of $1.02 billion Free Cash Flow of $169 million Returned $486 million to shareholders through share repurchases and dividends Fourth Quarter 2019 Results Net Sales of $1.4...

The Chemours Company Reports Second Quarter 2019 Results

Committed to Core Growth Strategy Despite Near Term Headwinds Second Quarter 2019 Highlights Net Sales of $1.4 billion Net Income of $96 million, with diluted EPS of $0.57 Adjusted Net Income of $120 million, with diluted Adjusted EPS of $0.72 Adjusted EBITDA of $283 million Returned $108 million to shareholders through share repurchases and dividends Other Highlights Completed the acquisition of ...